CheckMyRecalls

Pfizer recalls Dopamine HCl Inj.

Published
23 Sept 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

Brand / company
Pfizer
Codes / lots
Lot # NL5230, Exp Date:10/2027
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 23 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.